Non-pegylated liposomal doxorubicin (Myocet®®) in patients with poor-risk aggressive B-cell non-Hodgkin lymphoma.

Autor: Dell'olio, Matteo¹ (AUTHOR) matteodellolio@tiscali.it, Potito scalzulli, Rosario¹ (AUTHOR), Sanpaolo, Grazia¹ (AUTHOR), Nobile, Michele¹ (AUTHOR), Saverio mantuano, Francesco¹ (AUTHOR), La sala, Antonio¹ (AUTHOR), D'arena, Giovanni¹ (AUTHOR), Miraglia, Eustachio² (AUTHOR), Lucania, Anna³ (AUTHOR), Mastrullo, Lucia³ (AUTHOR), Nicola, Cascavilla¹ (AUTHOR)

Publikováno v: Leukemia & Lymphoma. Jul2011, Vol. 52 Issue 7, p1222-1229. 8p. 6 Charts, 3 Graphs.